Psychiatric complications in the treatment of Parkinson's disease
Identifieur interne : 000A89 ( PascalFrancis/Corpus ); précédent : 000A88; suivant : 000A90Psychiatric complications in the treatment of Parkinson's disease
Auteurs : Erik Ch. WoltersSource :
- Advances in neurology [ 0091-3952 ] ; 2001.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
pR |
|
Format Inist (serveur)
NO : | PASCAL 03-0237965 INIST |
---|---|
ET : | Psychiatric complications in the treatment of Parkinson's disease |
AU : | WOLTERS (Erik Ch.); CALNE (Donald); CALNE (Susan M.) |
AF : | Graduate School for Neurosciences Amsterdam, Department of Neurology, Academisch Ziekenhuis Vrije Universiteit/1081 HV Amsterdam/Pays-Bas (1 aut.); Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon/Vancouver, British Columbia/Canada (1 aut., 2 aut.) |
DT : | Publication en série; Congrès; Niveau analytique |
SO : | Advances in neurology; ISSN 0091-3952; Coden ADNRA3; Etats-Unis; Da. 2001; Vol. 86; Pp. 385-393; Bibl. 60 ref. |
LA : | Anglais |
CC : | 002B17G |
FD : | Parkinson maladie; Trouble psychiatrique; Complication; Traitement; Toxicité; Homme; Antiparkinsonien; Chimiothérapie |
FG : | Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie; Système nerveux pathologie |
ED : | Parkinson disease; Mental disorder; Complication; Treatment; Toxicity; Human; Antiparkinson agent; Chemotherapy |
EG : | Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Nervous system diseases |
SD : | Parkinson enfermedad; Trastorno psiquiátrico; Complicación; Tratamiento; Toxicidad; Hombre; Antiparkinsoniano; Quimioterapia |
LO : | INIST-15741.354000109446770400 |
ID : | 03-0237965 |
Links to Exploration step
Pascal:03-0237965Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Psychiatric complications in the treatment of Parkinson's disease</title>
<author><name sortKey="Wolters, Erik Ch" sort="Wolters, Erik Ch" uniqKey="Wolters E" first="Erik Ch." last="Wolters">Erik Ch. Wolters</name>
<affiliation><inist:fA14 i1="01"><s1>Graduate School for Neurosciences Amsterdam, Department of Neurology, Academisch Ziekenhuis Vrije Universiteit</s1>
<s2>1081 HV Amsterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0237965</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 03-0237965 INIST</idno>
<idno type="RBID">Pascal:03-0237965</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A89</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Psychiatric complications in the treatment of Parkinson's disease</title>
<author><name sortKey="Wolters, Erik Ch" sort="Wolters, Erik Ch" uniqKey="Wolters E" first="Erik Ch." last="Wolters">Erik Ch. Wolters</name>
<affiliation><inist:fA14 i1="01"><s1>Graduate School for Neurosciences Amsterdam, Department of Neurology, Academisch Ziekenhuis Vrije Universiteit</s1>
<s2>1081 HV Amsterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
<imprint><date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Complication</term>
<term>Human</term>
<term>Mental disorder</term>
<term>Parkinson disease</term>
<term>Toxicity</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Trouble psychiatrique</term>
<term>Complication</term>
<term>Traitement</term>
<term>Toxicité</term>
<term>Homme</term>
<term>Antiparkinsonien</term>
<term>Chimiothérapie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0091-3952</s0>
</fA01>
<fA02 i1="01"><s0>ADNRA3</s0>
</fA02>
<fA03 i2="1"><s0>Adv. neurol.</s0>
</fA03>
<fA05><s2>86</s2>
</fA05>
<fA08 i1="01" i2="1" l="ENG"><s1>Psychiatric complications in the treatment of Parkinson's disease</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Parkinson's disease</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>WOLTERS (Erik Ch.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>CALNE (Donald)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>CALNE (Susan M.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Graduate School for Neurosciences Amsterdam, Department of Neurology, Academisch Ziekenhuis Vrije Universiteit</s1>
<s2>1081 HV Amsterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA15>
<fA18 i1="01" i2="1"><s1>World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders"</s1>
<s3>INC</s3>
<s9>patr.</s9>
</fA18>
<fA18 i1="02" i2="1"><s1>Pacific Parkinsons Research Institute</s1>
<s3>CAN</s3>
<s9>patr.</s9>
</fA18>
<fA20><s1>385-393</s1>
</fA20>
<fA21><s1>2001</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>15741</s2>
<s5>354000109446770400</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>60 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0237965</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Advances in neurology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Trouble psychiatrique</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Mental disorder</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Trastorno psiquiátrico</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Complication</s0>
<s5>17</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Complication</s0>
<s5>17</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Complicación</s0>
<s5>17</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Traitement</s0>
<s5>18</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Treatment</s0>
<s5>18</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>18</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Toxicité</s0>
<s5>19</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Toxicity</s0>
<s5>19</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Toxicidad</s0>
<s5>19</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
<s5>21</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
<s5>21</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
<s5>21</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>22</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>22</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>22</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>41</s5>
</fC07>
<fN21><s1>146</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>Parkinson's Disease. International Congress</s1>
<s3>Vancouver CAN</s3>
<s4>1999-07-25</s4>
</fA30>
</pR>
</standard>
<server><NO>PASCAL 03-0237965 INIST</NO>
<ET>Psychiatric complications in the treatment of Parkinson's disease</ET>
<AU>WOLTERS (Erik Ch.); CALNE (Donald); CALNE (Susan M.)</AU>
<AF>Graduate School for Neurosciences Amsterdam, Department of Neurology, Academisch Ziekenhuis Vrije Universiteit/1081 HV Amsterdam/Pays-Bas (1 aut.); Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon/Vancouver, British Columbia/Canada (1 aut., 2 aut.)</AF>
<DT>Publication en série; Congrès; Niveau analytique</DT>
<SO>Advances in neurology; ISSN 0091-3952; Coden ADNRA3; Etats-Unis; Da. 2001; Vol. 86; Pp. 385-393; Bibl. 60 ref.</SO>
<LA>Anglais</LA>
<CC>002B17G</CC>
<FD>Parkinson maladie; Trouble psychiatrique; Complication; Traitement; Toxicité; Homme; Antiparkinsonien; Chimiothérapie</FD>
<FG>Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie; Système nerveux pathologie</FG>
<ED>Parkinson disease; Mental disorder; Complication; Treatment; Toxicity; Human; Antiparkinson agent; Chemotherapy</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Nervous system diseases</EG>
<SD>Parkinson enfermedad; Trastorno psiquiátrico; Complicación; Tratamiento; Toxicidad; Hombre; Antiparkinsoniano; Quimioterapia</SD>
<LO>INIST-15741.354000109446770400</LO>
<ID>03-0237965</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A89 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000A89 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:03-0237965 |texte= Psychiatric complications in the treatment of Parkinson's disease }}
This area was generated with Dilib version V0.6.29. |